TARS
Tarsus Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$90.78
+9.10%0
Insider buys (3m)
10
Insider sells (3m)
-$4.2M
Net value (3m)
+42.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Lin Elizabeth Yeu · officer: Chief Medical Officer | Sale | 5,387 | $80 |
| Sep 3, 2026 | Lin Elizabeth Yeu · officer: Chief Medical Officer | Sale | 4,601 | $74 |
| Sep 3, 2026 | Azamian Bobak R. · director, officer: President/CEO and Board Chair | Sale | 10,000 | $80 |
| Sep 3, 2026 | Lin Elizabeth Yeu · officer: Chief Medical Officer | Sale | 1,590 | $80 |
| Jun 29, 2026 | LINK WILLIAM J PHD · director | A-Award | 3,837 | $64 |
| Jun 29, 2026 | CHAUDHURI BHASKAR · director | A-Award | 2,417 | $0.00 |
| Jun 29, 2026 | LINK WILLIAM J PHD · director | A-Award | 806 | $0.00 |
| Jun 29, 2026 | YARNO WENDY L · director | A-Award | 1,209 | $0.00 |
| Jun 29, 2026 | LINK WILLIAM J PHD · director | A-Award | 2,417 | $0.00 |
| Jun 29, 2026 | Goodrich Katherine · director | A-Award | 3,837 | $64 |
| Jun 29, 2026 | PYOTT DAVID E I · director | A-Award | 3,837 | $64 |
| Jun 29, 2026 | YARNO WENDY L · director | A-Award | 3,837 | $64 |
| Jun 29, 2026 | Goldberg Andrew D. · director | A-Award | 3,837 | $64 |
| Jun 29, 2026 | Morrison Scott W · director | A-Award | 3,837 | $64 |
| Jun 29, 2026 | Morrison Scott W · director | A-Award | 2,417 | $0.00 |
| Jun 29, 2026 | Goodrich Katherine · director | A-Award | 2,417 | $0.00 |
| Jun 29, 2026 | PYOTT DAVID E I · director | A-Award | 2,417 | $0.00 |
| Jun 29, 2026 | PYOTT DAVID E I · director | A-Award | 806 | $0.00 |
| Jun 29, 2026 | CHAUDHURI BHASKAR · director | A-Award | 3,837 | $64 |
| Jun 29, 2026 | Goldberg Andrew D. · director | A-Award | 2,417 | $0.00 |
| Jun 29, 2026 | YARNO WENDY L · director | A-Award | 2,417 | $0.00 |
| Jun 22, 2026 | Azamian Bobak R. · director, officer: President/CEO and Board Chair | Sale | 5,418 | $62 |
| Jun 22, 2026 | Azamian Bobak R. · director, officer: President/CEO and Board Chair | Sale | 4,582 | $61 |
| Jun 17, 2026 | LINK WILLIAM J PHD · director | Sale | 1,928 | $63 |
| Jun 17, 2026 | Farrow Jeffrey S · officer: See Remarks | Sale | 14,396 | $61 |
| Jun 17, 2026 | Goodrich Katherine · director | Sale | 2,954 | $62 |
| Jun 17, 2026 | LINK WILLIAM J PHD · director | Sale | 10,572 | $62 |
| Jun 17, 2026 | Farrow Jeffrey S · officer: See Remarks | M-Exempt | 27,881 | $0.00 |
| Jun 16, 2026 | CHAUDHURI BHASKAR · director | M-Exempt | 2,954 | $0.00 |
| Jun 16, 2026 | LINK WILLIAM J PHD · director | M-Exempt | 2,954 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 89Increased 193Reduced 171Sold out 35
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 3,856,137 | Aug 7, 2026 |
| Deep Track Capital, LP | Increased | 3,666,768 | Aug 14, 2026 |
| DEEP TRACK CAPITAL, LP | Increased | 3,600,000 | May 15, 2026 |
| BLACKROCK, INC. | Reduced | 3,552,612 | May 13, 2026 |
| RTW INVESTMENTS, LP | Increased | 3,357,059 | Aug 14, 2026 |
| RTW INVESTMENTS, LP | Increased | 3,346,025 | May 15, 2026 |
| Jupiter Topco LLC | New Position | 2,808,796 | Aug 14, 2026 |
| Paradigm Biocapital Advisors LP | Increased | 2,775,649 | Aug 14, 2026 |
| PARADIGM BIOCAPITAL ADVISORS LP | Unchanged | 2,562,154 | May 15, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 2,240,963 | May 18, 2026 |
| MORGAN STANLEY | Reduced | 1,944,272 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 1,827,082 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 1,793,064 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,760,541 | May 15, 2026 |
| JENNISON ASSOCIATES LLC | Reduced | 1,712,124 | May 6, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026